PDS Biotechnology Corp (PDSB)
followers
·
Follow
Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Frank K. Bedu-Addo
Employees:
20
303A COLLEGE ROAD EAST, PRINCETON, NJ, 08540
800-208-3343
Date | Ratio |
---|---|
2019-03-18 | 1:20 |
PDS Biotechnology Corporation focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies, and cervical cancer. The company is also developing various product candidates, which are in preclinical trials.
All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
---|